Live feed
Filing
SC 13G
SC 13G0001104659-22-110633·CLS Therapeutics, LLC
Schedule 13G ownership disclosure
XENETIC BIOSCIENCES INC
Security class unavailable · CUSIP: 984015503
Event date: 2022-10-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,475,000
- Percent of class
- 9.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-110633
- Form type
- SC 13G
- Filer
- CLS Therapeutics, LLC
- CIK
- CIK 1951493
- Filed
- Oct 21, 2022
- Reporting period
- Oct 12, 2022
- Description
- Schedule 13G beneficial ownership